Skip to main content

National assessment of pharmaceutical workforce and education using the International Pharmaceutical Federation’s global development goals: a case study of Qatar



The sustainable development goals were launched by the United Nations in 2015. Its fifth goal was describing the achievement of universal health coverage by 2030. This goal reaffirms the importance of investing in the development and training of the global health workforce. In alliance with this, the International Pharmaceutical Federation (FIP) has published reports about pharmacy workforce planning in several countries. However, data about Qatar were not included in these reports. In 2017, FIP developed a transformational roadmap of pharmaceutical workforce and education. One systematic framework component of the roadmap is the Pharmaceutical Workforce Development Goals (DG[w]s) that were released in late 2016 and subsequently incorporated into the more comprehensive Global Development Goals1 in 2020, encompassing not only workforce development, but additionally practice and pharmaceutical science development. This study aimed to evaluate the current situation of pharmacy workforce and education in Qatar in relation to the original 13 Pharmaceutical Workforce Development Goals (DG[w]s). The objective was to identify the gaps in pharmacy workforce and education and to recommend evidence-led strategies to be included in both the Ministry of Public Health and the Qatar University College of Pharmacy workforce development plans.


Three rounds of conventional Delphi technique were conducted with expert panels of key decision-makers in pharmacy practice from the College of Pharmacy at Qatar University and the Ministry of Public Health, utilizing the FIP’s self-assessment survey. Qualitative content analysis was used to analyze and prioritize the identified gaps from the collected data. DG[w] was considered “met” if all the provided indicators were achieved, “partially met” if at least one of the indicators were achieved, and “not met” if none of the indicators were achieved


The lack of competency framework (DG[w]5), workforce data (DG[w]12), and workforce policy formation (DG[w]13) are three major gaps in the provision of pharmaceutical workforce and pharmacy education in Qatar, influencing other DG[w]s. These gaps need to be addressed by the formation of Qatar Pharmaceutical Association through which academic, practice, and policymaking sectors can work together in developing health workforce intelligence system.


The results indicated that DG[w]s are interrelated and a gap in one goal can negatively influence others. Results and recommendations of this research will facilitate the implementation of strategic plans across leading pharmacy sectors to meet health needs in Qatar and achieve the third pillar of the Qatar National Vision 2030.


The United Nations launched the sustainable development goals in 2015, which are global development targets, to be achieved by 2030—building on the millennium development goals that preceded them; the fifth sustainable development goal describes achieving universal health coverage including access to quality essential healthcare services for all citizens by 2030 [1].Footnote 1 This goal reaffirms the importance of investing in the development and training of the global health workforce especially as the availability of a capable, competent and accessible healthcare workforce is now a global challenge [1,2,3], which is a potential barrier to the improvement and development of national and global health services [4]. Hence, health workforce planning is a critical requirement in global healthcare agenda in an effort to achieve universal health coverage [5, 6].

Pharmacists have a key role in the delivery of primary and secondary healthcare [7], and factors such as increased complexity of medication therapies, increased complexity of co-morbidities and number of prescriptions have contributed to the demand of pharmacy workforce across all global regions [6]. Consequently, new entrants into the pharmacy workforce need to possess the skills and competencies needed to deliver efficient pharmaceutical and health services as part of the healthcare team [8]. Several substantial changes are required to be implemented by pharmacy schools, associations and employers in order to ensure a balance of demand and supply in the pharmacy workforce [9]. Analyses of the global pharmacy workforce have consistently showed that countries and territories with lower economic indicators tend to have fewer pharmacists and pharmacy technicians [10]. However, while the quantitative capacity of the pharmacy workforce is important, it is not the only factor: the ability of this workforce to meet the healthcare needs of populations is of equal importance [11].

The capacity of the pharmacy workforce varies both within and across the six World Health Organization (WHO) regions. For example, the estimated pharmacist density in northern countries in the region of the Americas, such as Canada and United States of America, are between 9.8 and 10.5 pharmacists per 10,000 population [12]. Countries in the Africa region tend to have fewer pharmacists per population compared to other regions; for example, pharmacist density is as low as 0.02 pharmacist per 10,000 population in Somalia [10]. In the Eastern Mediterranean Region (EMR), pharmacy practice continues to evolve coupled with highly varied capacity densities between countries within the region [13]. Recent estimated pharmacist densities in the EMR range from 1.6 (Bahrain) to 16.2 (Jordan) pharmacists per 10,000 population [12]. Furthermore, some countries in the EMR such as Jordan are considered as “exporters” of pharmacists to neighboring countries since the number of graduates are considered to exceed the need for that particular country but address the shortages of others [12]. For example, countries like Iraq and Bahrain are examples of countries with low pharmacist densities (3.3 and 1.6 per 10,000 population, respectively) where shortages of local graduates exists, and thus expatriate pharmacists are hired [12]. Other countries such as Qatar, United Arab Emirates and Saudi Arabia have moderate pharmacist density which are 8.9, 8.8 and 8.6 per 10,000 population, respectively.

The International Pharmaceutical Federation (FIP) is the global body representing the pharmacy profession including pharmaceutical sciences, practice and education. Through more than 140 national pharmacy organizations across the globe, FIP represents over four million pharmacists, pharmaceutical scientists and pharmaceutical educators worldwide [14]. In 2017, FIP published an analysis of trends in the global pharmacy workforce at three time points (years 2006, 2009 and 2012) providing baseline data on the current global trend regarding the number of pharmacists, capacity building, and mean percentage change in the pharmacist capacity [7]. The report indicated a shortage of pharmacy workforce in the low and middle-income countries [7] which includes many of the countries in the EMR. However, most of the available data regarding pharmacy workforce are from the regions of the Americas and Europe, despite the coverage of all six regions in the report [15]. It is worth noting that workforce planning literature from the United Kingdom, United States of America, and Canada have discussed the expected challenges in the pharmacy profession and have proposed potential solutions and actions [16, 17]. In these countries, actions have been taken and reports regarding these challenges have been sent to regulatory bodies in order to address the identified challenges [16, 17]. Profound professional actions were taken by the United Kingdom. These actions include inclusive workforce assessment and subsequent pharmacy stakeholders’ participation in workforce planning, which was followed by provision of potential solutions to the profession and public sectors. One consequence, coupled with a general market expansion of higher education, has been a large increase in the number of pharmacy schools, faculties and colleges over the previous 20 years [16, 17].

In EMR, studies conducted to address workforce intelligence and workforce development strategies are limited and the available published literature emphasizes workforce statistics without analyses of workforce planning and intelligence [18, 19]. For example, a published review in 2011, which included 13 EMR countries, reported that the number of pharmacists and pharmacy educational programs were increasing in the region, but did not provide suggestions about the effective utilization and development of the workforce [13]. In one EMR country—Qatar, the available literature suggested several challenges facing the pharmacy profession, including the absence of a national pharmacy association [11]. However, the literature emphasized that the support from the Qatar government through the Ministry of Public Health (MoPH) represents an opportunity for development in alignment with the Qatar National Vision 2030 [11, 20].

In 2017, FIP led the establishment of a global developmental roadmap that aims to transform pharmaceutical education and workforce by providing appropriate strategic tools to support and develop quality-driven pharmacy education and workforce planning [21]. FIP transformative workforce roadmap, which was developed by collaborative work and consensus from global stakeholders of pharmacy, is an evidence-generated roadmap with a global vision for transforming pharmacy [22]. One of the major components of the global roadmap are 13 global Development Goals specifically related to workforce (DG[w]s) grouped into three main clusters: academic, professional development, and systems, as illustrated in Appendix 1. The academic cluster includes three goals, focusing on schools, universities and education providers, and aims to assess academic capacity, foundation training and early career development and quality assurance. The professional development cluster includes five goals, focusing on the pharmaceutical workforce. The five goals aim to assess advanced and specialist expert development, competency development, leadership development, service provision and workforce education and training, and working with others in the healthcare team. Finally, the systems cluster includes five goals, focusing on policy development, governmental strategy planning and monitoring systems. The systems cluster goals aims to assess continuing professional development strategies, pharmaceutical workforce gender and diversity balances, workforce impact and effect on health improvement, workforce intelligence and workforce policy formation [21]. DG[w]s are considered a mapping framework and, hence, do not prioritize the proposed goals; instead, prioritization is left for local stakeholders, based on their individual country’s needs [21].

This study represents the first national-level research-oriented response in the EMR to FIP’s call for further concerted effort towards national cohesive workforce development and education, following their publication, at the EMR regional level coupled with the local imperatives for alignment with national health and policy visions [23]. The aims of this study were to: (1) evaluate and assess the current situation of pharmacy workforce, education, profession and system from different institutional and stakeholder perspectives in the State of Qatar in relation to the 13 DG[w]s; (2) identify the gaps in pharmacy workforce, education and practice development and; (3) recommend possible solutions as potential strategies to be included in the Ministry of Public Health (MoPH)’s and College of Pharmacy’s (CPH) at Qatar University (QU) future plans.


Study design

A conventional Delphi method was applied in this research study. This method was selected because it is a structured communication method for achieving consensus with target participants by using iterative rounds of questionnaires to collect data. The use of a conventional Delphi method in this research facilitated knowledge sharing and views broadening between the participants and stimulated the generation of new ideas about workforce development in Qatar [24,25,26,27]. This research method was adjusted in accordance with the current study’s proposed objectives about assessing the status of DG[w]s in Qatar, while maintaining the main features of the Delphi method [26, 28, 29].

Population and sampling

Professional leaders and policymakers in the MoPH (n = 6) were identified as key decision-makers in pharmacy practice relating to workforce development and licensing in Qatar and were invited to participate in the study. These individuals have the ability to influence practice policies and workforce development. Additionally, policymakers and leading educators in the CPH (n = 5) at QU—the country’s only pharmacy college—were identified as key decision-makers in pharmacy education and were invited to participate in the study. These individuals have the ability to influence pharmacy education’s policies and development in Qatar.

Study setting

This study was conducted in CPH at QU. The data were collected over 3 months between September and December 2018. The participants who were involved in the study received an information leaflet which included adequate information about the nature, purpose, and anticipated risk of the study. Written informed consent forms were obtained from the participants prior to their recruitment in the study.

Delphi tool and study instrument

FIP’s validated self-assessment survey tool was used for data collection in this study in order to assess the alignment of pharmacy practice and pharmacy education in Qatar with the DG[w]s. The tool was used in a 21-country global survey study conducted by FIP in 2017; the tool was initially drafted and peer-reviewed internally within FIP. The template was then sent to two contacts from member organizations to pilot the questions. Comments on clarity of the questions and response options available were received and changes were made accordingly before being released worldwide [23].

Data collection

Three rounds of Delphi were conducted; each round was more focused aiming to reach confirmation and consensus among participants. First Delphi round was done by sending the FIP’s validated self-assessment survey tool via e-mails to obtain individual responses (n = 6 from MoPH, n = 5 from CPH). Participants were asked to answer relevant question about DG[w]s related to their area of expertise (Participants from CPH answered questions related to academy cluster goals and participants from MoPH answered questions related to professional development and system cluster goals). Participants then sent the completed questionnaires back to the researcher by email, in order to retrieve and organize the collected data. In the second Delphi round, the researcher invited participants from MoPH (n = 6) to a meeting and participants from CPH (n = 5) to another meeting in order to conduct around the table detailed discussion about participants’ collected answers from the first round and their interpretation in order to elaborate further about their answers and reach consensus (consensus was ≥ 90% for all questions). The third Delphi round involved sending the consensed upon answers by email to each participant, who were asked to confirm their agreement on the reached consensus. Summary for the three rounds of the Delphi approach’s participants is shown in Table 1. All data collection sessions were conducted in English language and were recorded using a digital audio recorder to allow the researchers to focus on discussions and consensus achievement. Recorded sessions were manually transcribed by the researchers using the verbatim transcription and were double-checked for accuracy in transcription.

Table 1 Summary for the three rounds of the Delphi approach with participants from the Ministry of Public Health and college of pharmacy

Data analysis

A qualitative content analysis technique was used to analyze the collected data in this research. This method was chosen for analysis because it has the ability to focus on the context of the current situation of pharmacy practice and education in Qatar [30, 31]. Moreover, it highlights the similarities within, and the differences between, the different parts of the FIP validated survey and draws conclusions from the data [32, 33]. From the data collected, a goal was considered “met” if all the provided indicators were considered achieved by the participants’ consensus, “partially met” if at least one of the indicators were considered achieved by the consensus, and “not met” if none of the indicators were considered achieved by the consensus.


Academy cluster

All participants from CPH responded to the academy questions. The three goals in the academy cluster were “partially met”, as shown in Table 2, with each goal achieving more than half of its indicators (Fig. 1). It was reported by the participants from CPH that the present increase in academic capacity (DG[w] 1) was not based on national needs, meaning that one of its five indicators not achieved. One of the CPH’s participant responses, about this unachieved indicator, was as follows:

“I am not sure if there are serious discussions and strategic planning about workforce development agenda, plus any documents i.e. evidence that were shared at the college level regarding the needs of the country. Moreover, no proper manpower study for the pharmaceutical sector that was carried out and published/shared/circulated in CPH.” CPH3

Table 2 Summary of the responses of the indicators in each goal among the academy cluster
Fig. 1
figure 1

Percentages of indicators achievement in the academy cluster goals

According to CPH’s participants, DG[w]2, which focuses on foundation training and early career development, was partially met with one of its three indicators not achieved. This was due to the lack of early career maps and frameworks to support a seamless transition for the students into early career practice and towards advanced practice in the CPH. However, the first indicator of this goal, which focuses on the students’ foundational education and training was achieved. A CPH participants commented about this indicator, as follows:

“Yes, we are currently in alignment. Structured clinical practice training is embedded into our curriculum in both the BSc and PharmD programs which prepares students for practice”. CPH1

Study participants suggested that DG[w] 3, which focuses on the quality assurance processes, was partially met, with one of the four indicators not achieved. One possible reason for this indicator being not achieved is the absence of stakeholder input for training and education development. However, three indicators were achieved, for example, participants indicated that they have internal and external quality assurance at QU. For example, the following was mentioned by one of the CPH’s participants about the first achieved indicator:

“In 2016, we conducted an Academic Program Review, as requested by QU, where we invited two panel of experts from North America to review our curriculum”. CPH3

Another participant mentioned the following about the second achieved indicator:

“The CPH is in alignment with the quality assurance process. We are accredited by the Canadian Council for Accreditation of Pharmacy Programs for both BSc and PharmD. This accreditation ensures the quality of the education that is provided for our students”. CPH2

Professional development cluster

All participants from the MoPH responded to the professional development items. The professional development cluster includes five goals, for which one goal was “not met” and four goals were “partially met”. The responses on the professional development cluster are shown in Table 3 and the percentages of the achieved indicators for each goal are shown in Fig. 2. DG[w] 4, focussing on advanced and specialist expert development, was found by the study participants to be partially met with two of its three indicators not achieved. The evidence gaps were highlighting the need for a common and shared understanding of what is meant by “specialization training” and “advanced practice” in the context of scope of practice and the responsible use of medicines. About this indicator, a policymaker from the MoPH said:

“Qatar Council for Healthcare Practitioner as a regulatory authority does not conduct this kind of specialization training. However, number of accredited activities are conducted by healthcare organization and academic institution for pharmacists”. MoPH4

Table 3 Summary of the responses of the indicators in each goal among the professional development cluster
Fig. 2
figure 2

Percentages of indicators achievement in the professional development cluster goals

Study participants indicated that DG[w]5, which focuses on competency development, was not met because its three indicators were not achieved. The findings for DG[w] 5 suggest a lack of national finalized competency framework across all practice sectors in Qatar, which has reflected negatively on the first indicator of DG[w] 4.

DG[w] 6 has a focus on leadership development, and according to study participants this goal was partially met as two indicators were not achieved. One response about the only achieved indicator, by a professional leader from the MoPH, was:

“Qatar Council for Healthcare Practitioner has conducted few activities for the continuous profession development (CPD) teams of the CPD Providers to support in the educational planning of accredited CPD activities such as: Leadership Skills for CPD Professionals and Introduction to CPD Leadership course”. MoPH4

The study participants suggested that DG[w]7 (service provision and workforce education and training) was partially met with most of its indicators achieved through the systematic development of education and training activities based on local healthcare systems, their capacity and funding. For example, one of the MoPH’s policymakers said:

“The CPD accreditation system is intended to promote consistent quality and excellence in continuous medical education and professional development taking into account the national health profile, priorities, and workforce distribution”. MoPH3

The last goal in the professional development cluster (DG[w] 8) focuses on demonstrating the significance of pharmacists’ interprofessional education and collaboration with other healthcare professionals. The study participants indicated that this goal was partially met due to lack of evidence of policy formation that partnership development and engagement among healthcare professionals to achieve better health outcomes. One response from a professional leader in the MoPH about this goal stated:

“Although the National CPD program and accreditation system promotes interprofessional education of all health care practitioners including pharmacists, there is no clear policy formation evidence to guide the process”. MoPH2

Systems cluster

All participants from MoPH responded to the systems cluster items. The systems cluster includes five goals, from which two goals were “partially met”, while the remaining three goals were “not met”. The three goals in the system cluster were not met due to unachieved indicators, lack of critical data, or because the goals were still under development stage. The detailed responses on the professional development cluster are shown in Table 4 and the percentages of the achieved indicators for each goal are shown in Fig. 3.

Table 4 Summary of the responses of the indicators in each goal among the systems cluster
Fig. 3
figure 3

Percentages of indicators achievement in the systems cluster goals

Study participants suggested that DG[w] 9, which focuses on continuing professional development strategies, was partially met, because two indicators, which focuses on the effective continuing professional development strategies, were achieved. One participant’s response about these achieved indicators was:

“Qatar Council for Healthcare Practitioner continuous professional development activities’ accreditation standards mandate that all accredited activities must be planned to address the identified learning needs of the target audience. The needs assessment strategies include multiple sources of data to identify the needs of its target audience(s)”. MoPH3

Study participants indicated that DG[w]10, which addresses gender and diversity inequalities among the pharmacy workforce was partially met, because one of its three indicators were not achieved.

DG[w]11, which focuses on the workforce impact on health improvement, was not met, because one of its indicators needs further data to be exported from HMC, and the other indicator was not answered. However, one participant indicated the significance of this goal by stating:

“Participating in CPD activities would enhance the competence and performance of healthcare practitioners including pharmacists and, subsequently, ensure better healthcare service quality and patient care outcomes”. MoPH4

DG[w]12 has a focus on workforce intelligence and indicates that countries should have national strategies and corresponding actions to share workforce data and planning activities. Although this goal was not met directly, a profession leader in the MoPH commented that this goal is under development:

“The national continuous medical education/continuous profession development accreditation system promote stakeholder collaboration in CPD activity planning. In addition, the national needs-assessment strategy is planned to be formulated based on the available workforce data, perceived and unperceived educational needs assessment.” MoPH2.

The study findings suggest that DG[w]13 (workforce policy formation) was not met, as the two principal indicators remain under national development. The degree of achievement for all goals among the three clusters is illustrated in Fig. 4.

Fig. 4
figure 4

Degree of goals’ achievement among the three clusters


This study is a preliminary step towards pharmacy education and workforce transformation in Qatar through evaluating the current situation of pharmacy education and workforce using the FIP workforce development goals as a mapping framework. The discussion of the results was conducted in relation to the limited number of similar studies conducted in response to the establishment of FIP’s roadmap and DG[w]s, as well as in relation to studies discussing elements similar to those covered in DG[w]s.

The study findings suggest that DG[w]s are interdependent and correlated; a certain gap in one goal generally was associated with gaps across other goals. Examples of correlation between various DG[w]s is demonstrated through the discussion of DG[w]1, DG[w]5 and DG[w]12 and their influence on DG[w]3, DG[w]6 and DG[w]1, respectively. This finding about the correlation between DG[w]s is consistent with the key results of the seven international workshops, which discussed the global transformative roadmap for pharmaceutical workforce and covered all six WHO regions [34].

The research findings regarding DG[w]1 suggest that there is an increase in academic capacity associated with establishing the CPH in 2007, which increase is not based on published national needs. This ‘capacity gap’ between reality and policy need could be rooted in communication gaps that potentially exist between the policymakers in the MoPH and the CPH in workforce planning. This in turn may have potential links with the quality assurance goal in the academy cluster (DG[w] 3), as key stakeholders in the MoPH potentially did not have adequate input on CPH’s policy development. The capacity measures for pharmacy students and graduates, which are not mapped to any published national needs, can be attributed to gaps in workforce intelligence and workforce planning (DG[w] 12 in the system cluster). Previous literature by Bader et al. indicated the importance of considering national needs when planning academic capacity (DG[w] 1) through a workforce intelligence system [35]. Bader et al. provided an overview of the pharmacy workforce capacity trends in the EMR and demonstrated that the EMR countries have relatively high workforce capacity compared to other WHO regions. However, EMR demonstrated several challenges in workforce intelligence planning compared to other regions, such as poor planning and management of human resources, geographic and sectoral distribution imbalances, limited educational and training capacities, workforce shortages, and underemployment and these findings are consistent with this Qatar study [35].

Results report that DG[w] 2 is partially met, which potentially suggests a general lack of strategies for the foundation training and early career development. This potential lack of strategies could be attributed to absence of the frameworks to support the transition of students into early career and towards advanced practice in the CPH. Several studies in the literature have emphasized the significant impact of early career development of novice pharmacists in building future career success and professional outcomes [36, 37]. For example, Koen et al. argued that early career training has improved the career adaptability, career success and career confidence among the newcomers to the labor market [36].

With regard to DG[w] 3, the participants suggested an implementation of internal and external quality assurance measures at CPH. In addition, participants indicated that DG[w]3 has been influenced by the capacity gap’ between national need and policy need (DG[w]1). In this regard, Bruno et al. highlights variability in pharmacy education and quality assurance measures at both the regional and global levels [34]. Bruno et al. argued that this variability is caused by lack of competency frameworks and quality assurance systems [34] which emphasizes the significance of developing such quality assurance measures for pharmacy education in the EMR generally [8].

In this study, the advanced and specialist expert development goal (DG[w] 4) was considered to be partially met, principally due to lack of common and shared understanding of specialization and advanced practice. This finding is consistent with one of the suggestions reported by pharmacy stakeholders in the international workshops that took place in November 2016, which discussed the global transformative roadmap for pharmaceutical workforce [34]. The suggestion emphasized the significance of financial resources for driving advanced practice and specialization, because remuneration and financial motives enhance the provision of advanced services [34].

Although DG[w]5 was not met due to a lack of any unified competency framework across all pharmacy practice sectors, national efforts are taking place to develop one. The significance of having a clear competency development framework was stressed in the literature as a priority for workforce development [38, 39]. Battel-Kirk et al. and Wright et al. argued that utilizing a competency-based approach is beneficial in identifying the required competencies, which can ultimately enhance the quality of practice as well as address complex and changing demands for critical services [38, 39]. It is worth noting that the absence of competency development frameworks (DG[w] 5), has influenced progress towards meeting indicators for DG[w] 6 (leadership development), because leaders, as well, needs to adhere to common competencies in their leadership practices, which are lacking. This also links to the progress of DG[w] 4. In that regard, Zilz et al. indicated the significance of developing the professional leadership skills and competencies in creating high-performance pharmacy practices characterized by a productive and quality patient care services [40].

For DG[w] 7, which was partially met through the systematic development of education and training activities based on local healthcare systems, several studies in the literature highlighted the value of implementing a systematic development among pharmacy workforce’s education and training approaches, based on social determinants [41, 42]. For example, Wheeler et al. (2014) argued that flexible pharmacist-related education and training programs are required by all community pharmacy staff, because these programs will improve pharmacists’ knowledge and build their confidence in service provision for patients [41]. However, it is worth noting that several global key pharmacy stakeholder respondents who attended the Global Conference on Pharmacy and Pharmaceutical Education reported varying interpretations of DG[w] 7 [34]. For example, ‘foundation training’ was considered by some stakeholders as initial education rather than workforce education and training, and by others to relate to early career training [34].

With regard to DG[w] 8, the literature emphasized the significance of partnership development among healthcare professionals to achieve better health outcomes, which was partially met in this study. For example, Farrell et al. and El-Awaisi et al. stressed the value of interprofessional education and collaborative working on providing patient-centered care and in initiating a system-level intervention in order to improve healthcare outcomes [43, 44].

DG[w] 9 was considered to be partially met, but was classed by participants as a priority for development, indicating that all accredited activities must be planned to address the identified learning needs of the target audience. Several published studies have emphasized the significance of continuing professional development for the pharmacy workforce and considered it as an ethical requirement in different healthcare professions [45, 46]. Furthermore, continuing professional development for the pharmacy workforce is a commitment towards patients and quality healthcare delivery, and pharmacists should regularly engage with continuing professional development to apply advanced guidelines and strategies in their career [45, 47].

DG[w]10, that focuses on pharmaceutical workforce equity and diversity balances, was partially met with two of its indicators achieved. In that regard, the literature highlighted the importance of clear strategies to address gender and diversity balance across pharmacy workforce and to consider them in career development efforts [48,49,50]. Moreover, several studies indicated the significance of removing any barrier that negatively impact the active participation of all pharmacy workforce [48,49,50], which would ultimately improve the overall status of DG[w]10. For DG[w]11 (workforce impact and effect on health improvement), which was not met in this study because one of its indicators needs further data to be exported from HMC, several studies have illustrated the impact of the pharmaceutical workforce on health improvement [51, 52]. For example, Basheti et al. indicated that the pharmaceutical workforce has a key role in improving patients’ health outcomes in Jordan [51]. Furthermore, the value of pharmacy workforce interventions were considered as highly valuable in several countries [53, 54].

According to the findings, DG[w] 12, which focuses on workforce intelligence, was considered under development. A key obstacle in achieve DG[w] 12 in the State of Qatar is the absence of a national pharmacy association that represents and supports pharmacists nationally and internationally. The mentioned gap in workforce intelligence and workforce planning has influenced DG[w] 1, which focuses on capacity measures for pharmacy students and graduates.

This obstacle has been indicated in several previous studies that discussed the pharmacy profession and practice in Qatar [11, 55]. For example, Kheir and Fahey stressed the value of having a pharmacy association or agency in Qatar to enhance the transformation of pharmacy professional practice and to provide guidance [11]. In addition, the significance of having such associations or agencies for planning and developing workforce was stresses in several previous literature from different regions [56, 57]. Although pharmacy law in Qatar has a key role in controlling pharmacies, regulating pharmacists’ registration process, checking the structure of the pharmacies’ premises, and regulating medications’ use regulation, yet the key role of a national pharmacy association is non-replaceable.

Finally, DG[w] 13 was considered “not met” because the unified policies and strategies for professional development across all settings and stages are still under development. In that regard, a global report published in 2017 by the FIP emphasized the importance of having implementation plans to meet national-level pharmaceutical workforce strategies [58]. The report indicated that 21 countries reported on their progress towards achieving the 13 DG[w]s, and emphasized that policy and strategy formation and workforce intelligence (DG[w] 12 and 13) were key challenges for almost all countries [58].

The findings reported in this study offer an important first step in identifying and prioritizing gaps in pharmaceutical workforce planning and development in Qatar, and in encouraging aligned future research in other EMR countries. Such national–regional engagement activities would result in an opportunity to enhance EMR-wide efforts to strategically progress development of higher quality education and practice standards, and would offer an evidence-led case study for other WHO regions [23]. Moreover, overcoming the identified gaps in this study would ultimately contribute to the successful achievement of the third pillar of Qatar’s 2030 vision, which aims to build a comprehensive world-class healthcare system that is effective, affordable and universally available to all citizens [20].

One of the study’s limitations is lacking data from the pharmacy practice sectors whether governmental or private. However, since the MoPH is the governing body responsible for both private and public practice sectors, the provided data from MoPH participants was considered representative of the current situation among practice sectors in Qatar. Further research should focus on collecting data from the governmental and private practice sectors in order to represent a full image for the pharmacy practice in Qatar. Indeed, establishing a national pharmacy association in Qatar would ultimately result in the appropriate representation, monitoring, and reporting all pharmacy practice-related sectors’ status and concerns.

Another limitation for this study is the difficulty in how some DG[w]s and their associated indicators are understood and interpreted. This limitation can be attributed to a lack of universally accepted terminology or glossary of terms related to DG[w]s. Furthermore, DG[w]s and the utilized survey tool are newly developed and published (2017) and there is a dearth in the literature that can be used to compare and interpret the results of this study. This observation is supported by the summary note published by the key pharmacy stakeholders in the FIP, who attended the Global Conference on Pharmacy and Pharmaceutical Education. They suggested having a “terminology and definitions framework” to tackle different contextual meanings of the goals [34]. To address this limitation, researchers in this study met with FIP leaders to make sure that they fully understand the goals and the survey. Later on, the researchers met personally with the study participants and gave them a summary of each goal to ensure the proper understanding of the goals before giving their consensus on responses.

Furthermore, the research involved a small number of participants from MoPH and CPH (6 participants and 5 participants, respectively). However, those participants were the key decision-makers in pharmacy practice from MoPH and policymakers and leading educators in the CPH at QU.


This research was the first conducted in the State of Qatar and in the Eastern Mediterranean Region to evaluate the current situation of pharmacy education and practice and its alignment with the global Development Goals (workforce) in the State of Qatar. The DG[w]s developed by the FIP and global consensus have provided a transnational opportunity and integrated platform for comprehensive workforce development. This study has demonstrated its effectiveness in identifying and examining the current gaps of the pharmacy workforce in Qatar. This study has assessed the country-level context of the global DG[w]s in three clusters: academy, professional development, and systems. The results suggest that the disconnect between academic capacity planning and national health resources needs, the lack of evidence-based competency development in all professional career stages, and the undeveloped workforce policy and workforce intelligence are significant workforce development vulnerabilities and should be identified as priority policy gaps.

Future multinational research should focus on optimizing the terminologies and definition of frameworks which are being used globally to address the DG[w]s, in order to reach a better common shared understanding by all pharmacy educators, professionals and leaders around the world. Furthermore, based on our findings, we conclude that EMR countries should find ways of collaborating, in a transnational way, in order to enhance efficiencies in policy development identified by our study; in this way, the gaps in pharmacy education, practices and policies can be uniformly prioritized to initiate concerted workforce planning and prevent shortages or oversupply of pharmacists in all professional sectors. Additionally, future research should be conducted in Qatar in order to understand the practice sector vision and perspective with regard to relevant DG[w]s.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


  1. This manuscript will refer to the principal 13 Workforce Development Goals as “Development Goals (workforce)” or DG[w] throughout.



International Pharmaceutical Federation


The Pharmaceutical Workforce Development Goals


Ministry of Public Health


College of Pharmacy


Qatar University


World Health Organization


Eastern Mediterranean Region


Continuous profession development


  1. SDGs U. United Nations sustainable development goals. New York: UN Organisation; 2015.

    Google Scholar 

  2. Truth AU. No Health without a workforce. World Health Organisation (WHO) Report. Geneva: World Health Organisation; 2013.

    Google Scholar 

  3. Griggs D, Stafford-Smith M, Gaffney O, Rockström J, Öhman MC, Shyamsundar P, et al. Policy: sustainable development goals for people and planet. Nature. 2013;495(7441):305.

    Article  CAS  PubMed  Google Scholar 

  4. Ekpenyong A, Udoh A, Kpokiri E, Bates I. An analysis of pharmacy workforce capacity in Nigeria. J Pharm Policy prac . 2018;11(1):20.

    Article  Google Scholar 

  5. Johnson TJ. Pharmacist work force in 2020: implications of requiring residency training for practice. Am J Health Syst Pharm. 2008;65(2):166–70.

    Article  PubMed  Google Scholar 

  6. Hawthorne N, Anderson C. The global pharmacy workforce: a systematic review of the literature. Human Res health. 2009;7(1):48.

    Article  Google Scholar 

  7. John C, Bates I. Global pharmacy workforce intelligence: trends report 2015. 2015.

  8. Bajis D, Moles R, Chaar B. Stakeholders’ perspectives on quality assurance in the Eastern Mediterranean Region. Am J Pharm Educ. 2017.

    Article  Google Scholar 

  9. Lebovitz L, Eddington ND. Trends in the pharmacist workforce and pharmacy education. Am J Pharm Educ. 2019;83(1):7051.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bates I, John C, Bruno A, Fu P, Aliabadi S. An analysis of the global pharmacy workforce capacity. Human Res Health. 2016;14(1):1–7.

    Article  Google Scholar 

  11. Kheir NFM. Pharmacy practice in Qatar: challenges and opportunities. South Med Rev . 2011;4(2):6.

    Article  Google Scholar 

  12. Organization WH. Global Health Observatory data repository, Pharmaceutical personnel. Last updated: 2019-01-15. 2020. Accessed 16 Mar 2020.

  13. Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson PJ. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72(6):133.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Federation IP. Representing pharmacy, pharmaceutical sciences and pharmaceutical educators.

  15. Bates I, John C, Seegobin P, Bruno A. An analysis of the global pharmacy workforce capacity trends from 2006 to 2012. Human Res Health. 2018;16(1):3.

    Article  Google Scholar 

  16. Covvey JR, Cohron PP, Mullen AB. Examining pharmacy workforce issues in the United States and the United kingdom. Am J Pharm Educ. 2015;79(2):17.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Soon JA, Levine M. Rural pharmacy in Canada: pharmacist training, workforce capacity and research partnerships. Int J Circumpolar Health. 2011;70(4):407–18.

    Article  PubMed  Google Scholar 

  18. Fathelrahman A, Ibrahim M, Wertheimer A. Pharmacy practice in developing countries: achievements and challenges. Cambridge: Academic Press; 2016.

    Google Scholar 

  19. Sweileh WM, Al-Jabi SW, Sawalha AF, Zyoud S. Pharmacy education and practice in West Bank, Palestine. Am J Pharm Educ. 2009;73(2):38.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Planning GSfD. Qatar national vision 2030. Author Doha, Qatar; 2008.

  21. Bader L, Bates I, Schneider P, Charman W. Transforming pharmacy and pharmaceutical sciences education in the context of workforce development. UCL Discovery. 2017.

  22. Law M, Bader L, Uzman N, Williams A, Bates I. The FIP Nanjing Statements: Shaping global pharmacy and pharmaceutical sciences education. Res Soc Admin Pharm. 2019;15(12):1472–5.

    Article  Google Scholar 

  23. Mukhalalati B, Bader L, Alhaqan A, Bates I. Transforming the pharmaceutical workforce in the Eastern Mediterranean Region: a call for action. East Mediterr Health J. 2019.

    Article  Google Scholar 

  24. Lindeman CA. Priorities within the health care system: a Delphi survey. Maryland: American Nurses’ Association; 1981.

    Google Scholar 

  25. Young SJ, Jamieson LM. Delivery methodology of the Delphi: a comparison of two approaches. Journal of Park and Recreation Administration. 2001;19(1).

  26. Trevelyan EG, Robinson N. Delphi methodology in health research: how to do it? Eur J Integr Med . 2015;7(4):423–8.

    Article  Google Scholar 

  27. Pill J. The Delphi method: substance, context, a critique and an annotated bibliography. Socio Econ Plan Sci. 1971;5(1):57–71.

    Article  Google Scholar 

  28. Avella JR. Delphi panels: Research design, procedures, advantages, and challenges. Int J Dr Stud. 2016;11(1):305–21.

    Google Scholar 

  29. Skulmoski GJ, Hartman FT, Krahn J. The Delphi method for graduate research. J Info Tech Edu Res. 2007;6(1):1–21.

    Google Scholar 

  30. Mayring P. Qualitative content analysis: theoretical foundation, basic procedures and software solution. Klagenfurt. 2014; p. 143.

  31. Scheufele B. Content analysis, qualitative. In: Donsbach W, editor. The international encyclopedia of communication. Oxford: Blackwell; 2008. pp. 967–72.

    Chapter  Google Scholar 

  32. Graneheim UH, Lindgren B-M, Lundman B. Methodological challenges in qualitative content analysis: A discussion paper. Nurse Educ Today. 2017;56:29–34.

    Article  PubMed  Google Scholar 

  33. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–12.

    Article  CAS  PubMed  Google Scholar 

  34. Bruno A, Bader L, Bates I, Brock T, Galbraith K, Anderson C, et al. Structured multi-stakeholder workshops to advance a global transformative roadmap for pharmaceutical workforce. Innovat Pharm. 2018.

    Article  Google Scholar 

  35. Bader L, Bates I, John C. From workforce intelligence to workforce development: advancing the Eastern Mediterranean pharmaceutical workforce for better health outcomes. East Mediterr Health J . 2018;24(9):899–904.

    Article  PubMed  Google Scholar 

  36. Koen J, Klehe U-C, Van Vianen AE. Training career adaptability to facilitate a successful school-to-work transition. J Vocat Behav. 2012;81(3):395–408.

    Article  Google Scholar 

  37. Skledar SJ, Martinelli B, Wasicek K, Mark S, Weber RJ. Training and recruiting future pharmacists through a hospital-based student internship program. Am J Health Syst Pharm. 2009;66(17):1560–4.

    Article  PubMed  Google Scholar 

  38. Battel-Kirk B, Barry MM, Taub A, Lysoby L. A review of the international literature on health promotion competencies: identifying frameworks and core competencies. Global Health Promotion. 2009;16(2):12–20.

    Article  PubMed  Google Scholar 

  39. Wright K, Rowitz L, Merkle A, Reid WM, Robinson G, Herzog B, et al. Competency development in public health leadership. Am J Public Health. 2000;90(8):1202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Zilz DA, Woodward BW, Thielke TS, Shane RR, Scott B. Leadership skills for a high-performance. Am J Health-Syst Pharm. 2004;61:2562–74.

    Article  PubMed  Google Scholar 

  41. Wheeler A, Mey A, Kelly F, Hattingh L, Davey AK. Education and training for community pharmacists in mental health practice: how to equip this workforce for the future. JMHTEP. 2014;9(3):133–44.

    Article  Google Scholar 

  42. Kennerly J, Weber RJ. Role of pharmacy education in growing the pharmacy practice model. Hosp Pharm. 2013;48(4):338.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Farrell B, Ward N, Dore N, Russell G, Geneau R, Evans S. Working in interprofessional primary health care teams: what do pharmacists do? Res Soc Admin Pharm. 2013;9(3):288–301.

    Article  Google Scholar 

  44. El-Awaisi A, Joseph S, El Hajj MS, Diack L. A comprehensive systematic review of pharmacy perspectives on interprofessional education and collaborative practice. Res Soc Admin Pharm. 2018;14(10):863–82.

    Article  Google Scholar 

  45. Kheir N, Wilbur K. Continuing professional development and self-learning for pharmacists. In: Pharmacy education in the twenty first century and beyond. Amsterdam: Elsevier; 2018, p. 191–200.

  46. Micallef R, Kayyali R. A systematic review of models used and preferences for continuing education and continuing professional development of pharmacists. Pharmacy. 2019;7(4):154.

    Article  PubMed Central  Google Scholar 

  47. Rouse MJ, Trewet CB, Janke KK. Advancing learning to advance pharmacy practice. J Am Pharm Assoc . 2018;58(2):151–5.

    Article  Google Scholar 

  48. Hassell K. The impact of social change on professions—gender and pharmacy in the UK: an agenda for action. Int J Pharm Prac . 2000;8(1):1–9.

    Article  Google Scholar 

  49. Bottero W. The changing face of the professions? Gender and explanations of women’s entry to pharmacy. Work Employ Soc. 1992;6(3):329–46.

    Article  Google Scholar 

  50. Reichenbach L, Brown H. Gender and academic medicine: impacts on the health workforce. BMJ. 2004;329(7469):792–5.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Basheti IA, Al-Qudah RA, Obeidat NM, Bulatova NR. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial. Int J Clin Pharm. 2016;38(2):404–13.

    Article  PubMed  Google Scholar 

  52. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–36.

    Article  PubMed  Google Scholar 

  53. de Ramalho Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. JMCP. 2010;16(3):185–95.

    Article  Google Scholar 

  54. Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573–80.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Kheir N. Pharmacy practice in Qatar. In: Pharmacy practice in developing countries. Amsterdam: Elsevier; 2016, p. 233-52.

  56. Willis G, Cave S, Kunc M. Strategic workforce planning in healthcare: a multi-methodology approach. Eur J Oper Res. 2018;267(1):250–63.

    Article  Google Scholar 

  57. Addicott R, Maguire D, Honeyman M, Jabbal J. Workforce planning in the NHS. London: King’s Fund; 2015.

    Google Scholar 

  58. Federation IP. FIP report highlights work by RPS and GPhC on workforce development. Pharm J. 2017.

    Article  Google Scholar 

Download references


The authors would like to acknowledge the funding agency Qatar University internal student grant QUST-1-CPH 2019-10. In addition, the authors would like to thank all research participants from CPH and MoPH who participated in this study.


Open access funding provided by the Qatar National Library. This study was funded by Qatar University [Internal Grant number: QUST-1-CPH 2019-10]. Open Access funding provided by the Qatar National Library.

Author information

Authors and Affiliations



BM, LB, IB and AA conceptualized and designed the study. MI, MA and BM collected and analyzed the data. MI, MA, BM, AA, IB and LB wrote the first draft of the manuscript. All authors commented on previous versions of the manuscript. All authors read, edited, and approved the final manuscript of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Banan Abdulrzaq Mukhalalati.

Ethics declarations

Ethics approval and consent to participate

Exempt research certificate was obtained from the MoPH’s Research Division and an ethical approval was obtained from Qatar University Institutional Review Board (QU- IRB 973-E/18). Written informed consent forms were obtained from the participants prior to their recruitment in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.



See Table 5.

Table 5 The Pharmaceutical Workforce Development Goals description

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukhalalati, B.A., Ibrahim, M.M.M.E., Al Alawneh, M.O. et al. National assessment of pharmaceutical workforce and education using the International Pharmaceutical Federation’s global development goals: a case study of Qatar. J of Pharm Policy and Pract 14, 22 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: